Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL891852 | 1.00 | TSHR (0.57) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL6912492 | 1.00 | TSHR (0.57) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL9330598 | 0.94 | RXRA (0.56) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| Terephthalic Acid SCHEMBL4243136 | 0.85 | TSHR (0.71) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| Terephthalic Acid SCHEMBL338413 | 0.85 | TSHR (0.71) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| Terephthalic Acid SCHEMBL28509987 | 0.85 | TSHR (0.71) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL18039464 | 0.84 | RXRA (0.47) | SRD5A2CA1CA2CA12CA9 | |
| SCHEMBL372015 | 0.83 | TSHR (0.60) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL31192242 | 0.83 | TSHR (0.60) | TSHRTP53ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL28847652 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2SRD5A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109134410-A | The synthetic method of fluoro- 3- methyl isobenzofuran -1 (3H) -one of 5- | 沈阳药科大学 | 2019-01-04 | — | — | CN | claimed |
| WO-2024123929-A1 | DEVELOPMENT OF POTENT DUAL HDAC/BRD4 INHIBITORS | BIOVENTURES, LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| US-20230391812-A1 | RUTHENIUM COMPLEX, PRODUCTION METHOD OF THE COMPLEX, AND PRODUCTION METHOD OF OPTICALLY ACTIVE SECONDARY ALCOHOLS USING THE COMPLEX AS CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-12-07 | — | — | US | disclosed |
| EP-4230603-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAID COMPLEX, AND METHOD FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL USING SAID COMPLEX AS CATALYST | Takasago International Corporation (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-116323522-A | Ruthenium complex, process for producing the same, and process for producing optically active secondary alcohol using the same as catalyst | 高砂香料工业株式会社 | 2023-06-23 | — | — | CN | disclosed |
| CN-109134410-A | The synthetic method of fluoro- 3- methyl isobenzofuran -1 (3H) -one of 5- | 沈阳药科大学 | 2019-01-04 | — | — | CN | disclosed |
| WO-2011073487-A1 | PROCEDURE FOR THE ENANTIOSELECTIVE ADDITION OF ORGANOZINC COMPOUNDS TO COMPOUNDS DERIVED FROM ACETOPHENONES | UNIVERSIDAD DE VALLADOLID (ES) | 2011-06-23 | — | — | WO | disclosed |
| US-6720439-B1 | EFFICIENT REDUCTION OF BASE SENSITIVE CARBONYL COMPOUNDS; SEPARATING RACEMIC CARBONYL COMPOUNDS; CHIRAL CATALYSTS | NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) | 2004-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391812-A1 | RUTHENIUM COMPLEX, PRODUCTION METHOD OF THE COMPLEX, AND PRODUCTION METHOD OF OPTICALLY ACTIVE SECONDARY ALCOHOLS USING THE COMPLEX AS CATALYST | ADH5, ADH1A, ADH1C | TSHR 1898/4885TP53 4303/4885ALDH1A1 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.